Dr. Namareq Aldardeer is a skilled Critical Care Clinical Pharmacist currently working at King Faisal Specialist Hospital and Research Center-Jeddah branch (KFSHRC-J). She obtained her Doctor of Pharmacy degree from King Abdulaziz University in Jeddah, Saudi Arabia, in 2012. Dr. Aldardeer went on to complete her postgraduate year-1 (PGY1) residency at KFSHRC-J in 2018 and her PGY2 residency in critical care specialty at King Saud University Medical City-Riyadh in 2020.
Dr. Namareq is an American board-certified expert in pharmacotherapy, critical care, and nutrition support. With over a decade of experience in pharmacy services and clinical work, she is committed to advancing patient care in the ICU and has a strong interest in training and research. Her research contributions include:
"Percent Fluid Overload for the Prediction of the Need for Fluid De-resuscitation in Critically Ill Patients: A Single-Centre Prospective Cohort Study" (Preprint, September 2022)
"Early vs. Late ß-Lactam Antibiotic Dose Adjustment in Patients With Sepsis and Acute Kidney Injury" (Poster, March 2021)
"Early vs. Late ß-Lactam Antibiotic Dose Adjustment in Patients With Sepsis and Acute Kidney Injury" (Article, January 2021)
"Antifungal resistance in patients with Candidaemia: a retrospective cohort study" (Article, January 2020).